Algert Global LLC Syros Pharmaceuticals, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$4.46 - $9.2 $144,013 - $297,068
-32,290 Closed
0 $0
Q4 2019

Feb 18, 2020
BUY
$4.52 - $10.1 $145,950 - $326,129
32,290 New
32,290 $223,000
Q3 2019

Nov 14, 2019
SELL
$7.14 - $11.65 $127,948 - $208,768
-17,920 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $98,560 - $174,720
17,920 New
17,920 $166,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email